Here's why this ASX 200 healthcare share is racing 5% higher

This ASX 200 healthcare share is charging higher today…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price is ending the week on a high.

In afternoon trade, the private hospital operator's shares are beating the ASX 200 index with a 5% gain to $62.02.

A doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.

Image source: Getty Images

Why is the Ramsay share price beating the ASX 200?

Investors have been bidding the Ramsay share price higher on Friday following the release of the company's first quarter update.

According to the release, activity levels improved across all regions over the quarter compared to the prior corresponding period. Management advised that this reflects the decline in COVID cases in the community.

In light of this, the COVID impact on its profits in Australia and the UK fell from $44 million in July to just $5.9 million in September. The total impact across the quarter in these markets is estimated to have been $64.4 million.

Ramsay also revealed that it has been fighting rising costs. It advised that it is focused on negotiating improved terms with payors to reflect higher staffing costs related to labour shortages and inflationary pressures. Management notes that it finalised satisfactory new agreements with a number of private payors over the quarter.

This ultimately led to Ramsay reporting a 6.7% increase in revenue to $3,445.4 million and a 2.3% decline in EBITDA to $410.6 million for the first quarter.

Outlook

Pleasingly, this momentum has carried over into October, with Ramsay starting the second quarter positively. Looking ahead, management appears optimistic that it is onwards and upwards from here.

It commented:

The outlook for the Group remains strong as the business is well placed to take advantage of the positive long-term dynamics driving the healthcare industry. Ramsay expects a gradual recovery through FY23 and more normalised conditions from FY24.

The Ramsay share price remains down 13.5% in 2022 despite today's decline.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Young businesswoman sitting in kitchen and working on laptop.
Healthcare Shares

Up 15% in a week, is it too late to buy rebounding CSL shares?

CSL shares trade on roughly 13 times forecast FY26 earnings and offer a good dividend yield.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

Young woman thinking with laptop open.
Healthcare Shares

Why are Sigma Healthcare shares in the spotlight this week?

Is the latest sell-off overdone?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Is it time to get greedy with Pro Medicus shares?

The company was swept up in the huge sector-wide downturn in late 2025 and early 2026 as investors turned their…

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development.
Healthcare Shares

Prediction: I think Telix shares could double in value in 2026. Here's why

The biopharmaceutical company's shares dipped to a three-year low in February, but have now rebounded strongly.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

How much does UBS think CSL will bounce back?

If the worst is over, what's the upside for the shares?

Read more »

Woman with long hair smiles for the camera.
Healthcare Shares

Why I'd buy CSL shares while sentiment is weak

The market no longer treats this ASX healthcare giant as flawless, and that may make the investment case more interesting.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Is this exciting healthcare stock a buy, hold or sell after rocketing 16% yesterday?

Can this soaring stock keep rising?

Read more »